Laukien Family Member Sells 2M Bruker Shares | GenomeWeb

NEW YORK (GenomeWeb News) – Bruker said today that a member of the Laukien family sold two million of the company's shares in a block trade, and that CEO Frank Laukien bought 100,000 shares from the same family member in a private transaction.

The life science and environmental research tools maker, which now has a public float of 50.9 million shares, said that the unidentified Laukien family member is not involved in the company's business. The aggregate number of shares sold yesterday amounts to 12.6 percent of the selling shareholder's ownership.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.